Development and evaluation of image preprocessing pipelines for the Centiloid method on Down Syndrome data.
Published version
Peer-reviewed
Repository URI
Repository DOI
Change log
Abstract
BACKGROUND: Centiloid provides a standardized process to quantify brain amyloid in which a subject's T1 magnetic resonance imaging (MRI) and amyloid positron emission tomography (PET) scans are registered and warped to Montreal Neurological Institute 152 space using prescribed procedures. The method has a high failure rate in Down syndrome (DS) subjects from the Neurodegeneration in Aging Down Syndrome (NiAD) project. We evaluate imaging preprocessing methods (PMs) to improve the DS success rate. METHODS: PMs were constructed from combinations of image origin reset, filtering, MRI bias correction, and MRI skull stripping. Centiloid results were evaluated for adherence to standards using The Global Alzheimer's Association Interactive Network dataset. PMs were also evaluated using the NiAD dataset to judge their suitability for the DS population. DS PM evaluation procedures were developed corresponding to those specified for non-DS populations. RESULTS: Five accepted PMs improved the Centiloid-processing success rate in the DS cohort from 61.3% to 95.6%. DISCUSSION: The identified combinations of preprocessing steps substantially improved the success rate of Centiloid processing in DS. HIGHLIGHTS: Image preprocessing pipeline is proposed for Centiloid analysis of DS. Preprocessing pipelines are evaluated for adherence to Centiloid standards. Pipelines are evaluated for improvement in yield of usable imaging data. Preprocessing of amyloid imaging data resulted in a large yield improvement.
Description
Publication status: Published
Funder: Investigation of Co‐occurring conditions across the Lifespan to Understand Down Syndrome
Funder: DS‐Connect
Funder: National Institute on Aging; doi: https://doi.org/10.13039/100000049
Funder: NIHR Applied Research Collaboration East of England
Journal Title
Conference Name
Journal ISSN
1552-5279
Volume Title
Publisher
Publisher DOI
Rights and licensing
Sponsorship
Alzheimer's Disease Research Centers Program (P50 AG008702, P30 AG062421, P50 AG16537, P50 AG005133, P50 AG005681, P30 AG062715, P30 AG066519, P30 AG066468, P30 AG072973)
Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Centers Program (P50 HD105353)
National Center for Advancing Translational Sciences (UL1 TR001873, UL1 TR002373, UL1 TR001414, UL1 TR001857, UL1 TR002345, UL1 TR002366)
National Centralized Repository for Alzheimer Disease and Related Dementias (U24 AG21886)
National Institute for Health and Care Research (NIHR) Cambridge Biomedical Research Centre (NIHR203312)

